Skip to main content
. 2021 Sep 9;92:102604. doi: 10.1016/j.bcmd.2021.102604

Fig. 2.

Fig. 2

Hemogram parameters according to the severity of the disease observed in COVID-19 patients with or without comorbidities. Serum from COVID-19 patients (G1: Group 1 – mild; G2: Group 2 – moderate, and G3: Group 3 – severe) or control individuals (Control) was obtained and used to quantify neutrophils (A–C) and lymphocytes (D–F), and to calculate the neutrophil to lymphocyte ratio (NLR) of all patients studied (A, D, G) or of non-T2DM (B, E, H), and non-obese (C, F, I) patients. Dashed line intervals indicate the normal range of neutrophil and lymphocyte numbers and the normal limit for NLR. Kruskal-Wallis test followed by Dunn's multiple comparison test for all graphs except C (One-Way ANOVA followed by Holm-Sidak's multiple comparison test). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 compared to control group; &p < 0.05, &&p < 0.01, &&&p < 0.001, and &&&&p < 0.0001 compared to G1 group; #p < 0.05, ## p < 0.01 compared to G2 group.